INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation UnitedHealth Group Inc. (NYSE: UNH) and Urges Investors with Substantial Losses to Contact the Firm

21.02.25 18:41 Uhr

Werte in diesem Artikel
Aktien

478,55 EUR 0,80 EUR 0,17%

NEWTOWN, Pa., Feb. 21, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws and breaches of fiduciary duties involving UnitedHealth Group Inc. (NYSE: UNH) resulting from allegations of providing potentially misleading business information to the investing public through improper business practices which are being investigated by the United States Justice Department.

Edelson Lechtzin LLP (PRNewsfoto/Edelson Lechtzin LLP)

If you have non-public information that could assist in the UnitedHealth investigation or if you are a UnitedHealth investor who suffered a loss and would like to learn more, you can provide your information HERE.

You can also contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 ext. 1 or via e-mail at elechtzin@edelson-law.com.

THE COMPANY: UnitedHealth is a company specializing in health insurance and health care services.

THE ALLEGED WRONGDOING: On February 21, 2025, The Wall Street Journal and other news agencies reported that the DOJ was involved in a civil fraud investigation concerning UnitedHealth's practices related to patient diagnoses forced higher payments from the government's Medicare Advantage program. Currently more than half of Medicare recipients get their benefits through Medicare Advantage.

Insurers receive reimbursement for treatment based on the diagnostic codes presented to the Medicare Advantage program. Typically, insurers get paid more for patients with more severe illnesses. In recent years, the Biden administration attempted to constrain payments to Medicare Advantage plans, which lawmakers, watchdogs, and whistleblowers have accused of wasting tax dollars. Reporting suggests that the current probe emerged out of concerns about UnitedHealth's acquisitions of healthcare providers and data companies.

UnitedHealth stock is down approximately 9% in the wake of this news.

ABOUT EDELSON LECHTZIN LLP: Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class and collective litigation in cases alleging violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and catastrophic injuries.

For more information, please contact:

Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492 or 215-867-2399 ext. 1
Email: medelson@edelson-law.com
Email: elechtzin@edelson-law.com
Web:  www.edelson-law.com 

This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so counsel does not represent you unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing now. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investigation-alert-edelson-lechtzin-llp-announces-investigation-unitedhealth-group-inc-nyse-unh-and-urges-investors-with-substantial-losses-to-contact-the-firm-302382476.html

SOURCE Edelson Lechtzin LLP

In eigener Sache

Übrigens: UnitedHealth und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf UnitedHealth

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf UnitedHealth

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu UnitedHealth Inc.

Wer­bung

Analysen zu UnitedHealth Inc.

DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
09.11.2016UnitedHealth Group NeutralMizuho
31.03.2011UnitedHealth Group performOppenheimer & Co. Inc.
08.02.2011UnitedHealth Group neutralGoldman Sachs Group Inc.
15.11.2010UnitedHealth Group holdStifel, Nicolaus & Co., Inc.
20.04.2010UnitedHealth neutralWedbush Morgan Securities Inc.
DatumRatingAnalyst
11.06.2009UnitedHealth underperformOppenheimer & Co. Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für UnitedHealth Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen